Jul 09, 2019
Venclexta (venetoclax; AbbVie/Roche) Drug Overview & Product Profile 2017-2026: A Novel B-Cell Lymphoma 2 (BCL-2) Inhibitor that Received an Accelerated US FDA Approval
Jul 08, 2019
Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation
Jun 27, 2019
Letairis (ambrisentan; Gilead/GlaxoSmithKline) Market to 2025: A Selective Endothelin Type A Receptor Antagonist
Jun 26, 2019
Orenitram (treprostinil; United Therapeutics) Market Overview - Newer Brand Uptravi (selexipag; Johnson & Johnson/Nippon Shinyaku) Poses Tough Competition in the Oral Prostacyclin Class
Jun 26, 2019
Opsumit Drug Profile 2016-2025: Opsumit (macitentan; Johnson & Johnson/Nippon Shinyaku) is Set to Become the Market Leader with Forecast Peak Sales of $2.2bn in 2025
Jun 26, 2019
Tracleer (bosentan; Johnson & Johnson) Drug Overview & Product Profiles 2016-2025
Jun 18, 2019
Correvio Announces Voting Results
Jun 18, 2019
The BRAF kinase inhibitors market will register a CAGR of over 8% by 2023
May 20, 2019
New Post-hoc Analysis Shows Adding UPTRAVI® (selexipag) Versus Placebo Improved Long-Term Clinical Outcomes Regardless of Time of Treatment Initiation, and Demonstrated an Even More Pronounced Treatment Effect When Initiated Early
May 01, 2019
Correvio to Report First Quarter 2019 Financial Results on May 8, 2019
Mar 07, 2019
Correvio to Present at Upcoming Investor Conferences
Nov 16, 2018
Medicure Files Patent Infringement Action
Nov 14, 2018
India Saccharin Market Report 2018: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2023 - ResearchAndMarkets.com
Nov 01, 2018
Lannett Enters Into Distribution Agreement For Vardenafil Hydrochloride Tablets
Oct 30, 2018
Correvio to Report Third Quarter 2018 Financial Results on November 6, 2018
Sep 20, 2018
Correvio to Participate In Upcoming Investor Conferences
Aug 28, 2018
Correvio to Participate in Upcoming Investor Conferences
Aug 16, 2018
Dronedarone Promotes Cardiac Repair After a Heart Attack
Aug 01, 2018
Theravance Biopharma, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
Jun 28, 2018
Avella Selected by Array BioPharma Inc. to distribute BRAFTOVI(TM) (encorafenib) and MEKTOVI® (binimetinib)